All Stories

Boston Scientific plans to make ground despite $200M in tariff headwinds

Boston Scientific believes it can absorb the hit based on the continuing growth of its franchises in cardiology and urology.

Apr 24, 2025 - 17:57
 0
Boston Scientific plans to make ground despite $200M in tariff headwinds
Boston Scientific believes it can absorb the hit based on the continuing growth of its franchises in cardiology and urology.
Read More

Tags:

Previous Article

Walmart, Target, Home Depot tout productive meeting with Trump as tariffs threat...

Next Article

Chanel opens immersive pop-up to celebrate its new fragrance

Related Posts

Takeda's $300M bet on Protagonist's blood cancer drug pays off with phase 3 win

Takeda's $300M bet on Protagonist's blood cancer drug p...

Mar 3, 2025  0

Novo Nordisk links CagriSema to 16% weight loss, sending stock down again

Novo Nordisk links CagriSema to 16% weight loss, sendin...

Mar 10, 2025  0

Beam gene therapy for protein deficiency passes early safety test, sets efficacy bar in space: analyst

Beam gene therapy for protein deficiency passes early s...

Mar 10, 2025  0